首页> 外文期刊>Nutrition & Diabetes >Real-life achievement of lipid-lowering treatment targets in the DIAbetes and LifEstyle Cohort Twente: systemic assessment of pharmacological and nutritional factors
【24h】

Real-life achievement of lipid-lowering treatment targets in the DIAbetes and LifEstyle Cohort Twente: systemic assessment of pharmacological and nutritional factors

机译:糖尿病和LifEstyle队列特温特降脂治疗目标的实际实现:药理和营养因素的系统评估

获取原文
           

摘要

Background/Objectives Lowering low-density lipoprotein cholesterol (LDLc) in type 2 diabetes mellitus is of paramount importance in preventing cardiovascular disease. However, treatment targets for LDLc are often not reached. We studied the prevalence of LDLc target achievement in a real-life population of type 2 diabetes mellitus patients in secondary care, and investigated whether in those not on target, there is room for intensifying pharmacological and lifestyle management according to current treatment guidelines. Subjects/Methods We performed a cross-sectional analysis in the DIAbetes and LifEstyle Cohort Twente-1 (DIALECT-1; n ?=?450, age 63?±?9 years, 58% men, diabetes duration 11 (7–18) years). At baseline, we determined plasma LDLc concentration, pharmacological treatment (i.e., statin use), and lifestyle (physical activity and dietary intake). Patients were divided according to LDLc? ?2.5?mmol/l. Dietary intake was collected from a validated Food Frequency Questionnaire (177 items) and we determined guideline adherence for different food groups. Physical activity was assessed with the Short Questionnaire to ASsess Health enhancing behavior. Results LDLc data were available in 428 type 2 diabetes mellitus patients. LDLc?≤?2.5?mmol/l was achieved in 317 patients (76%). In total, 76% of patients used statins, in those with LDLc?>?2.5?mmol/l, this was 44%. Adherence to lifestyle guidelines was not different between the LDLc groups and was as follows: body mass index 6%, physical activity 59%, vegetables 7%, fruit 28%, legumes 59%, nuts 14%, dairy 19%, fish 36%, tea 8%, fats 66%, red meat 12%, processed meat 2%, alcohol 71%, sweetened beverages 34%, and sodium 12%. Conclusions In type 2 diabetes mellitus patients in secondary health care, the target LDLc is achieved by three quarters of patients. Increasing statin treatment could be a first step to improve LDLc. In addition, there are ample opportunities for lifestyle management through increasing adherence to lifestyle guidelines.
机译:背景/目的降低2型糖尿病的低密度脂蛋白胆固醇(LDLc)对预防心血管疾病至关重要。但是,LDLc的治疗目标通常无法达到。我们研究了在二级保健中的真实生活中的2型糖尿病患者中LDLc目标实现的普遍性,并根据当前的治疗指南调查了在未达到目标的人群中是否存在加强药理和生活方式管理的空间。受试者/方法我们在糖尿病和LifEstyle队列Twente-1(DIALECT-1;n≥450,年龄63±9岁,男性58%,糖尿病病程11(7-18)中进行了横断面分析年份)。在基线时,我们确定了血浆LDLc浓度,药物治疗(即他汀类药物的使用)和生活方式(体力活动和饮食摄入)。根据LDLc对患者进行划分? ≤2.5≤mmol/ l。饮食摄入量来自经过验证的食物频率问卷(177个项目),我们确定了不同食物组的准则遵守情况。通过评估健康状况的短期问卷评估了体育活动。结果428例2型糖尿病患者可获得LDLc数据。 LDLc≤≤2.5?mmol / l在317例患者中达到(76%)。在LDLc≥2.5?mmol / l的患者中,总共有76%的患者使用他汀类药物,占44%。 LDLc组之间遵循生活方式准则的情况无异,如下所示:体重指数6%,体育锻炼59%,蔬菜7%,水果28%,豆类59%,坚果14%,乳制品19%,鱼36% ,茶8%,脂肪66%,红肉12%,加工肉2%,酒精71%,甜饮料34%和钠12%。结论在二级保健中的2型糖尿病患者中,四分之三的患者达到了目标LDLc。增加他汀类药物治疗可能是改善LDLc的第一步。此外,通过增加对生活方式准则的遵守,生活方式管理还有很多机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号